Skip to main content
Log in

Tissue expression of the cancer-associated antigens ca 19-9 and ca-50 in chronic pancreatitis and pancreatic carcinoma

  • Published:
International journal of pancreatology Aims and scope Submit manuscript

Summary

The expression of the gastrointestinal cancer-associated antigens CA 19-9 and CA-50 was studied in 43 ductal pancreatic carcinomas, 1 mutinous cystadenoma, 1 signet-ring-cell carcinoma, 42 pancreata with chronic pancreatitis, and 10 normal fetal and adult pancreata. The anti-CA-50 antibody gave a more intense and more uniformly distributed staining of the ductal epithelial cells than the anti-CA 19-9 antibody. Both antigens, however, exhibited the same staining pattern of ductal epithelial cells in normal pancreas and chronic pancreatitis. Well differentiated carcinomas showed a predominantly membrane-bound antigen expression, whereas moderately and poorly differentiated carcinomas gave a more diffuse cytoplasmic staining. Epithelial dysplasia could not be differentiated by the staining pattern from normal, hyperplastic, metaplastic, or neoplastic cells. The immunohistochemical reaction with these anticarbohydrate antibodies, therefore, does not allow a qualitative discrimination between chronic pancreatitis and pancreatic carcinoma. CA 19-9, which expression depends on the Lewis gene, was negative in two patients with Lea-b- phenotype. Although anti-CA-50 antibody was reactive with the cancer cells of these 2 patients, the staining was weak and heterogenous.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arps H, Dietel M, Klapdor R, Kremer B. Immunhistologische Expression der neuen tumorassoziierten Antigene CA 19-9, CA 125, CA 17-1A and CA-50 in gastrointestinalen Tumoren-Spezifität und Sensitivität. In Greten H, Kalpdor R, Klinische Relevanz neuer monoklonaler Antikörper, 3. Hamburger Symposium über Tumormarker, Thieme Verlag, Stuttgart, 1986.

    Google Scholar 

  2. Atkinson BF, Ernst CS, Herlyn M, Steplewski Z, Sears HF. Gastrointestinal cancerassociated antigen in immunoperoxidase assay, Cancer Research, 1982; 42: 4820–4823.

    PubMed  CAS  Google Scholar 

  3. Becker V. Chronische Pankreatitis. Klinische Morphologie, Gastroenterologie und Stoffwechsel, Band 21, Thieme Verlag, Stuttgart-New York, 1984.

    Google Scholar 

  4. Dienst C, Clodius T, Oldörp T, Uhlenbruck G, Diehl V. CA 19-9, CA-50 und CEA bei Pankreas- und Gastrointestinaltumoren. Vergleichende Untersuchungen, Med. Klin., 1987; 82: 45–50.

    CAS  Google Scholar 

  5. Dietel M, Arps H, Müller-Hagen S, Klapdor R, Sieck M, Hoffmann L. Antigen detection by the monoclonal antibodies CA 19-9 and CA-125 in normal and tumor tissue and patients’ sera, J. Cancer Res. Clin. Oncol., 1986; 111: 257–265.

    Article  PubMed  CAS  Google Scholar 

  6. Dietel M, Arps H, Müller-Hagan S, Kalpdor R, Sieck M, Hoffmann L. Vergleichende Untersuchungen der Tumormarker CA-125, CA 19-9, CEA, CA 17-1A und CA-50 in Gewebeschnitten von Ovarialtumoren und den zugehörigen Patientenseren. In: Greten H, Klapdor R. Klinische Relevanz monoklonaler Antikörper, 3. Hamburger Symposium über Tumormarker, Thieme Verlag, Stuttgart, 1986.

    Google Scholar 

  7. Farini R, Fabris C, Bonvicini P, Piccoli A, Del Favero G, Venturini R, Panucci A, Naccarato R. CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis, Eur. J. Cancer Clin. Oncol., 1985; 21: 429–432.

    Article  PubMed  CAS  Google Scholar 

  8. Geyer G, Scheibner C. Untersuchungen über die alkalische Hydrolyse von Nukleinsäuren im Gewebeschnitt. IV. Abbaueffekte an Kohlenhydratverbidungen nach verstärkter Hydrolyse. Zugleich ein Beitrag zur Histochemie der Glykokalix, Acta histochem., Jena, 1970; 37: 148–153.

    CAS  Google Scholar 

  9. Haglund C, Lindgren J, Roberts PJ, Nordling S. Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis, Br. J. Cancer, 1986; 53: 189–195.

    PubMed  CAS  Google Scholar 

  10. Haglund C, Lindgren J, Roberts PJ, Nordling S. Tissue expression of the tumour marker CA-50 in benign and malignant pancreatic lesions. A comparison with CA 19-9, Int. J. Cancer, 1986; 38: 841–846.

    CAS  Google Scholar 

  11. Haglund C, Roberts PJ, Lindgren J, Jalanko H, Kunsel AP, Nordling S. Serum concentration and tissue expression of CA 19-9 and CA-50 in pancreatic cancer, 4. Hamburger Symposium über Tumormarker. Ed.: Greten H, Klapdor R. Thieme Verlag, Stuttgart, 1987.

    Google Scholar 

  12. Heptner G, Domschke S, Schneider MU, Siegfried W, Domschke W. Vergleich der Tumormarker CA-50 and CA 19-9 bei benignen und malignen Erkrankungen des oberen Gastrointestinaltraktes, Dtsch. med. Wschr., 1986; 111: 374–378.

    PubMed  CAS  Google Scholar 

  13. Herlyn M, Shen JW, Sears HF, Civin CI, Koprowski H. Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants, Clin. Exp. Immunol., 1984; 55: 22–35.

    Google Scholar 

  14. Holmgren J, Lindholm L, Persson B, Lagergard T, Nilsson O, Svennerholm N, Unsgaard B, Yngavson F, Petterson S, Killander AF. Detection by monoclonal antibody of carbohydrate antigen CA-50 in serum of patients with carcinoma, Br. med. J., 1984; 288: 1479–1482.

    Article  CAS  Google Scholar 

  15. Klöppel G, Lingenthal G, von BülowM, Kern HF. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases, Histopathology, 1985; 9: 841–856.

    Article  PubMed  Google Scholar 

  16. Koprowski H, Herlyn M, Steplewski Z, Sears HF. Specific antigen in serum of patients with colonoc carcinoma. Science, 1981; 212: 53–54.

    Article  PubMed  CAS  Google Scholar 

  17. Lindholm L, Holmgren J, Svennerholm L, Fredman P, Nilsson O, Persson B, Myrvold H, Lagergard T. Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides, Int. Arch. Allergy appl. Immun., 1983; 71: 178- 181.

    CAS  Google Scholar 

  18. Magnani JL, Nilsson B, Brockhaus B, Zopf D, Steplewski Z, Koprowski H, Ginsburg Y. A monoclonal antibody defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II, J. Biol. Chem., 1982; 257: 14365- 14369.

    PubMed  CAS  Google Scholar 

  19. Makovitzky J. The localization and distribution of the carbohydrate antigen 19-9 (CA 19-9) in chronic pancreatitis and pancreatic carcinoma, Virchows Arch. (Cell. Pathol.), 1986; 51: 535–544.

    Article  CAS  Google Scholar 

  20. Mansson JE, Fredman P, Nilsson O, Lindholm L, Holmgren J, Svennerholm L. Chemical structures of carcinoma ganglioside antigens defined by monoclonal antibody C-50 and some allied gangliosides of human pancreatic adenocarcinoma, Biochem. Biophys. Acta, 1985; 834: 110–117.

    PubMed  CAS  Google Scholar 

  21. Nilsson O, Mansson JE, Lindholm L, Holmgren J, Svennerholm L. Sialolyllactotetra-osylceramide, a novel monoclonal antibody defined ganglioside antigen detected in human carcinomas, FEBS Lett., 1985; 182: 398–402.

    Article  PubMed  CAS  Google Scholar 

  22. Pasquali C, Sperti C, d’Andréa AA, Catalini S, de Luca A, Bonadimani B, Cappellazzo F, Pedrazzoli S. The tumor-associated antigen CA-50 in the differential diagnosis of chronic pancreatitis (ChP) and pancreatic cancer (PC). Comparison with CA 19-9 and CA-125, XVIII Meeting of the European Pancreatic Club, 1986 (Abstract).

  23. Pour PM, Uchida E, Takahashi H, Tempero MA. Blood group antigenicity of gastrointestinal cancer, 4. Hamburger Symposium über Tumormarker. Ed.: Greten H, Kalpdor R. Thieme Verlag Stuttgart, 1987.

    Google Scholar 

  24. Pour PM, Takasaki H, Büchler M. Immunologie der akuten und chronischen Pankreatitis, Verh. Dtsch. Ges. Path., 1987; 71: 255–265.

    CAS  Google Scholar 

  25. Pugliese V, Paganizzi M, Aste H, Ferrara GB, Santi L. A clinical evaluation of the tumorassociated antigens CA-50 and CA 19-9 in benign and malignant pancreatobiliary diseases, Digestive Diseases and Sciences, 1986; (Suppl.) 81: 68.

    Google Scholar 

  26. Quintarelli G, Tsuiki S, Hashimoto Y, Pigman W. Histochemical studies of bovine salivary gland mucins, Biochem. Biophys. Res. Comm., 1960; 2: 423–433.

    Article  Google Scholar 

  27. Romhanyi G. Differences in ultrastructural organization of amyloid as revealed by sensitivity or resistance to induced proteolysis, Virchows Arch. (Path. Anat.), 1972; 357: 29–52.

    CAS  Google Scholar 

  28. Schmiegel H, Eberl W, Kreiker C, Kalthoff H, Bützow GW, Jessen K, Klapdor R, Soehendra N, Wargenau M, Classen M, Greten H, Thiele HG. Multiparametric tumor marker (Ca 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases, Hepato-gastroenterol., 1985; 32: 141–145.

    CAS  Google Scholar 

  29. Stolte M, Volkholz H, Becker V. Zur Differentialdiagnose Chronische Pankreatitis und Pankreascarcinom, Verh. Dtsch. Ges. Pathol., 1979; 63: 671.

    Google Scholar 

  30. Uhlenbruck G, Hanisch FG, Vierbuchen M, Dienst C. Biochemistry and histochemistry of new tumor markers (CA-125, CA 19-9, CA-50)—Relation to blood group antigens, 4. Hamburger Symposium über Tumormarker. Ed.: Greten H., Klapdor R. Thieme Verlag, Stuttgart, 1986.

    Google Scholar 

  31. Volkholz H, Stolte M, Becker V. Epithelial dysplasias in chronic pancreatitis, Virchows Arch. (Pathol. Anat.), 1982; 396: 331–349.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwenk, J., Makovitzky, J. Tissue expression of the cancer-associated antigens ca 19-9 and ca-50 in chronic pancreatitis and pancreatic carcinoma. Int J Pancreatol 5, 85–98 (1989). https://doi.org/10.1007/BF02925701

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02925701

Key Words

Navigation